021-51111890
购物车（）
sales@molnova.cn
PAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base)
CAS No. ——
PAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base) ( —— )
产品货号. M22901 CAS No. ——
PAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥3227 | 有现货 |
|
| 10MG | ￥5390 | 有现货 |
|
| 25MG | ￥8567 | 有现货 |
|
| 50MG | ￥13118 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述PAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
-
产品描述PAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体PAR-4
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量908.84
-
分子式C38H50F6N8O11
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(O)C(F)(F)F.OC1=CC=C(C[C@H](NC([C@@H](N)C)=O)C(N2CCC[C@H]2C(NCC(N[C@@H](CCCCN)C(N[C@@H](CC3=CC=CC=C3)C(N)=O)=O)=O)=O)=O)C=C1.O=C(O)C(F)(F)F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.A. Annaházi, Dabek M , Gecse K , et al. Proteinase-activated receptor-4 evoked colorectal analgesia in mice: an endogenously activated feed-back loop in visceral inflammatory pain[J]. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 2012, 24(1):76-0.
产品手册
关联产品
-
NSC622608
NSC622608 is a small-molecule ligand for V-domain Ig suppressor of T-cell activation (VISTA) which is an immune checkpoint that affects the ability of T-cells to attack tumors.
-
Pomalidomide-PEG3-CO...
Thalidomide-NH-PEG3-propionic acid is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-NH-PEG3-propionic acid incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
-
EGFRvIII peptide PEP...
PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
